Pharma Industry News Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT) 3 years ago
Pharma Industry News FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy 3 years ago
Pharma Industry News FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment 3 years ago
Healthcare News • Pharma Industry News Kwara PSN Wins 2022 Professional Body of the Year Award 3 years ago
Healthcare News • Pharma Industry News A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases 3 years ago